701 PIKE STREET, SEATTLE, WA
Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Avalyn Pharma Expands Lease with CRISPR Therapeutics by 4,934 Sq Ft
Regulation FD Disclosure
Reports First Quarter 2026 Financial Results and Recent Business Highlights
News, Articles of Incorporation, Bylaws
Q2
Q1
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Registration of Securities
Amended Registration Statement for Securities
S-1
No filings found
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership